FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer | NEJM
Original Article from The New England Journal of Medicine — FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Related Articles
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence
Pathologic complete response after neoadjuvant treatment in pancreatic ductal adenocarcinoma is a rare occurrence. Similar to other malignancies, achieving a pathologic complete response in pancreatic…
The Far-Reaching Ripple Effects of a Discredited Cancer Study
A flawed study attracted grants, investments and other researchers who based new work on the faulty findings.
Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer
Abstract. KRAS inhibitors demonstrate clinical efficacy in pancreatic ductal adenocarcinoma (PDAC); however, resistance is common. Among patients with KRASG12C-mutant PDAC treated with adagrasib or sotorasib,…
Dendritic Cell–Based Immunotherapy in Patients With Resected Pancreatic Cancer | Journal of Clinical Oncology
PURPOSE Immunotherapies have shown limited responses in patients with advanced pancreatic cancer. Recently, we reported that dendritic cell (DC)–based immunotherapy induced T-cell responses against pancreatic…
A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma
AbstractLessons Learned. The safety profile in the gemcitabine/simtuzumab group was similar to that in the gemcitabine/placebo group.The addition of simtuz
CPRIT awards more than $60 million to boost Texas’ fight against cancer — Cancer Prevention and Research Institute of Texas
Texans voted in 2007 to create the Cancer Prevention & Research Institute of Texas (CPRIT) and to invest $3 billion in the state’s unprecedented fight…
Identifying a gene signature of metastatic potential by linking pre-metastatic state to ultimate metastatic fate
Identifying the key molecular pathways that enable metastasis by analyzing the eventual metastatic tumor is challenging because the state of the founder subclone likely changes…
Ketogenic diet reshapes cancer metabolism through lysine β-hydroxybutyrylation
Nature Metabolism – Multi-omics analysis of mouse livers shows that protein β-hydroxybutyrylation (Kbhb) is strongly affected by the ketogenic diet. Combining bioinformatics with experimental…
FDA approves EpiPen alternative, a nasal spray for anaphylaxis
For years, people at risk of severe allergic reaction have had to rely on epinephrine auto-injectors like EpiPens. The FDA just approved the first nasal…
FDA approves EpiPen alternative, a nasal spray for anaphylaxis
For years, people at risk of severe allergic reaction have had to rely on epinephrine auto-injectors like EpiPens. The FDA just approved the first nasal…